Change Healthcare Inc. (CHNG) Tops Q4 EPS by 6c, Revenues Beat

Change Healthcare Inc. (NASDAQ: CHNG) reported Q4 EPS of $0.42, $0.06 better than the analyst estimate of $0.36. Revenue for the quarter came in at $855.2 million versus the consensus estimate of $840.53 million.

Financial Summary

• Total revenue of $855.2 million, including solutions revenue of $804.3 million
• Net loss of $13.1 million, resulting in net loss of $0.04 per diluted share
• Adjusted net income of $134.0 million, resulting in adjusted net income of $0.42 per diluted share
• Adjusted EBITDA of $272.0 million

“The fourth quarter performance demonstrates the execution of our growth strategy, delivering on our financial objectives while continuing to make investments to support our customers and employees, and advance our capabilities,” said Neil de Crescenzo, president and chief executive officer. “As we enter fiscal 2022, we remain focused on delivering the next phase of growth by advancing our technology-first approach to innovation and further integrating our diverse capabilities to advance connectivity, enhance efficiency, and drive better experiences and outcomes throughout the healthcare industry.”

Guidance

Due to the recently announced transaction with OptumInsight, we will no longer be providing financial guidance.

For earnings history and earnings-related data on Change Healthcare Inc. (CHNG) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c
• Optimum Communications gets NYSE non-compliance notice over stock price